Skip to Main Content

Author Details

Harim Koo
Korea University College of Medicine
2018
15
8
PMIDPaper TitleJournal TitlePublished Year
36915208Pharmacogenomic profiling reveals molecular features of chemotherapy resistance in IDH wild-type primary glioblastoma.Genome Med2023
36949068IGFBP5 is an ROR1 ligand promoting glioblastoma invasion via ROR1/HER2-CREB signaling axis.Nat Commun2023
33479772Modulation of Nogo receptor 1 expression orchestrates myelin-associated infiltration of glioblastoma.Brain2021
33828082Mutation-specific non-canonical pathway of PTEN as a distinct therapeutic target for glioblastoma.Cell Death Dis2021
31096737Clinical Targeted Next-Generation sequencing Panels for Detection of Somatic Variants in Gliomas.Cancer Res Treat2020
32070411Comprehensive pharmacogenomic characterization of gastric cancer.Genome Med2020
33142709Therapeutic Efficacy of GC1118, a Novel Anti-EGFR Antibody, against Glioblastoma with High EGFR Amplification in Patient-Derived Xenografts.Cancers (Basel)2020
32605068Multi-Habitat Radiomics Unravels Distinct Phenotypic Subtypes of Glioblastoma with Clinical and Genomic Significance.Cancers (Basel)2020
32794373Ethnic delineation of primary glioblastoma genome.Cancer Med2020
32120790Sphere-Forming Culture for Expanding Genetically Distinct Patient-Derived Glioma Stem Cells by Cellular Growth Rate Screening.Cancers (Basel)2020
30959925Elucidation of Novel Therapeutic Targets for Acute Myeloid Leukemias with <i>RUNX1</i>-<i>RUNX1T1</i> Fusion.Int J Mol Sci2019
29939324Identification of genomic and molecular traits that present therapeutic vulnerability to HGF-targeted therapy in glioblastoma.Neuro Oncol2019
31370279Novel Semi-Replicative Retroviral Vector Mediated Double Suicide Gene Transfer Enhances Antitumor Effects in Patient-Derived Glioblastoma Models.Cancers (Basel)2019
30759398Phenotypic Plasticity of Invasive Edge Glioma Stem-like Cells in Response to Ionizing Radiation.Cell Rep2019
29573206Identification of transcriptome signature for predicting clinical response to bevacizumab in recurrent glioblastoma.Cancer Med2018
  • 1 - 15 of 15

Recommended Authors

Jeff Liu
Princess Margaret Cancer Centre, University Health Network and University of Toronto
Career Start Year 2016
Number of shared co-authors 0
Chirayu Chokshi
McMaster University
Career Start Year 2015
Number of shared co-authors 0
Vikas Patil
Princess Margaret Hospital
Career Start Year 2013
Number of shared co-authors 0
Hiromichi Suzuki
Graduate School of Medicine, Kyoto University
Career Start Year 2012
Number of shared co-authors 5
Veronique Frattini
Institute for Cancer Genetics, Columbia University Medical Center
Career Start Year 2011
Number of shared co-authors 8
Carl Koschmann
University of Michigan-Ann Arbor
Career Start Year 2010
Number of shared co-authors 0
Felix Sahm
Hopp Children's Cancer Center Heidelberg (KiTZ)
Career Start Year 2010
Number of shared co-authors 5
Ping Zhu
McGovern Medical School, The University of Texas Health Science Center at Houston
Career Start Year 2009
Number of shared co-authors 0
Maxim Sidorov
California Pacific Medical Center Research Institute
Career Start Year 2009
Number of shared co-authors 0
Qianghu Wang
Center for Global Health, School of Public Health, Nanjing Medical University
Career Start Year 2009
Number of shared co-authors 16
Siyuan Zheng
Greehey Children's Cancer Research Institute
Career Start Year 2007
Number of shared co-authors 8
Joanna J Phillips
University of California san francisco
Career Start Year 2006
Number of shared co-authors 9
David Capper
Charite University Medicine Berlin
Career Start Year 2005
Number of shared co-authors 3
Verlene Henry
The MD Anderson Cancer Center
Career Start Year 2005
Number of shared co-authors 1
Mario L Suv??
Broad Institute of MIT and Harvard
Career Start Year 2004
Number of shared co-authors 1
Roel G W Verhaak
Yale School of Medicine
Career Start Year 2004
Number of shared co-authors 42
Anita B Hjelmeland
University of Alabama at Birmingham
Career Start Year 2004
Number of shared co-authors 2
Debyani Chakravarty
Memorial Sloan Kettering Cancer Center
Career Start Year 2002
Number of shared co-authors 1
Massimo Squatrito
Seve Ballesteros Foundation Brain Tumor group
Career Start Year 2002
Number of shared co-authors 5
Ghazaleh Tabatabai
University Hospital Tubingen, Eberhard-Karls-University Tubingen
Career Start Year 1998
Number of shared co-authors 5
Christopher Ryan Miller
University of Illinois at Urbana-Champaign
Career Start Year 1996
Number of shared co-authors 2
Vinay K Puduvalli
The University of Texas MD Anderson Cancer Center
Career Start Year 1996
Number of shared co-authors 2
Pim J French
Erasmus MC Cancer Institute
Career Start Year 1995
Number of shared co-authors 5
Paul S Mischel
Stanford University
Career Start Year 1994
Number of shared co-authors 0
Frank B Furnari
University of California San Diego
Career Start Year 1992
Number of shared co-authors 2
Jeremy N Rich
UPMC Hillman Cancer Center, University of Pittsburgh Medical Center
Career Start Year 1992
Number of shared co-authors 9
Donald M O'Rourke
Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania
Career Start Year 1991
Number of shared co-authors 0
Howard A Fine
Meyer Cancer Center
Career Start Year 1990
Number of shared co-authors 6
Howard Colman
Huntsman Cancer Institute, University of Utah
Career Start Year 1990
Number of shared co-authors 4
Kenneth Aldape
National Cancer Institute
Career Start Year 1985
Number of shared co-authors 9

Collaborators

Do-Hyun Nam
Samsung Medical Center, Sungkyunkwan University School
Co-authored papers 13
Jason K Sa
Korea University, College of Medicine
Co-authored papers 9
Hee Jin Cho
Touro College of Osteopathic Medicine
Co-authored papers 8
Seung Won Choi
Samsung Medical Center, Sungkyunkwan University
Co-authored papers 7
Doo-Sik Kong
Samsung Medical Center, Sungkyunkwan University School of Medicine
Co-authored papers 7
Ho Jun Seol
Samsung Medical Center, Sungkyunkwan University School of Medicine
Co-authored papers 6
Donggeon Kim
Institute for Refractory Cancer Research, Samsung Medical Center
Co-authored papers 6
Hyemi Shin
Research Institute for Future Medicine, Samsung Medical Center
Co-authored papers 6
Jung-Il Lee
Gangnam Severance Hospital
Co-authored papers 5
Yun Jee Seo
Institute for Refractory Cancer Research, Samsung Medical Center
Co-authored papers 4
Hye Won Lee
Yonsei University College of Medicine, Severance Hospital
Co-authored papers 4
Yong Jae Shin
Cancer Stem Cell Research Center, Samsung Biomedical Research Institute
Co-authored papers 4
Woong-Yang Park
Samsung Genome Institute, Samsung Medical Center
Co-authored papers 3
Kyeung Min Joo
Cancer Stem Cell Research Center, Samsung Biomedical Research Institute
Co-authored papers 2
Heon Yoo
Neuro-Oncology Clinic, National Cancer Center
Co-authored papers 2
Mijeong Lee
Kyungpook National University
Co-authored papers 2
Jeong-Woo Oh
Institute for Refractory Cancer Research, Samsung Medical Center
Co-authored papers 2
Chul-Kee Park
College of Medicine, Seoul National University
Co-authored papers 2
Jong Bae Park
Henan-Macquarie University Joint Centre for Biomedical Innovation, Henan University
Co-authored papers 2
Jin-Ku Lee
Seoul National University, College of Medicine
Co-authored papers 2
Sung Soo Kim
Institute of Vision Research, Yonsei University College of Medicine
Co-authored papers 2
Jung Won Choi
Samsung Medical Center, Sungkyunkwan University School of Medicine
Co-authored papers 2
Jeeyun Lee
Samsung Medical Center, Sungkyunkwan University School of Medicine
Co-authored papers 1
In-Hee Lee
Co-authored papers 1
Dongquan Chen
University of Alabama at Birmingham
Co-authored papers 1
Sung Heon Kim
Sungkyunkwan University
Co-authored papers 1
Yong-Jun Kwon
Luxembourg Institute of Health
Co-authored papers 1
Min Gew Choi
Research Institute, National Cancer Center
Co-authored papers 1
Shi-Yuan Cheng
Northwestern University Feinberg School of Medicine
Co-authored papers 1
Yeon-Lim Suh
Samsung Medical Center, Sungkyunkwan University College of Medicine
Co-authored papers 1
Release 1.2